Macrophages are major cells in IL-1β-induced suppression of anti-tumor immunity

被引：0
|
作者：
Apte, R. [1 ]
Kaplanov, I. [1 ]
Carmi, Y. [2 ]
Kornetsky, R. [1 ]
Voronov, E. [1 ]
机构：
[1] Ben Gurion Univ Negev, Beer Sheva, Israel
[2] Tel Aviv Univ, Tel Aviv, Israel
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W1-O4
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [41] Dasatinib Effect on NK Cells and Anti-Tumor Immunity
    Lachota, Mieszko
    Siernicka, Marta
    Pilch, Zofia
    Graczyk-Jarzynka, Agnieszka
    Winiarska, Magdalena
    BLOOD, 2018, 132
  • [42] The role of dendritic cells in cancer and anti-tumor immunity
    Marciscano, Ariel E.
    Anandasabapathy, Niroshana
    SEMINARS IN IMMUNOLOGY, 2021, 52
  • [43] Modification of anti-tumor immunity by tolerogenic dendritic cells
    Chen, Liying
    Hasni, Mohammad Sharif
    Jondal, Mikael
    Yakimchuk, Konstantin
    AUTOIMMUNITY, 2017, 50 (06) : 370 - 376
  • [44] TH9 cells in anti-tumor immunity
    Vargas, Thaiz Rivera
    Humblin, Etienne
    Vegran, Frederique
    Ghiringhelli, Francois
    Apetoh, Lionel
    SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (01) : 39 - 46
  • [45] Suppression of anti-tumor immunity by E2F3
    Wang, Hui
    Chen, Hui-Zi
    Wu, Lizhao
    de Bruin, Alain
    House, Melissa
    Ng, Stanley
    Johnson, Jackie
    Goldenberg, Larry
    Fang, Xiaohuang
    Fernandez, Soledad
    Stephens, Julie
    Naidu, Shan
    Stromberg, Paul
    Rosol, Thomas
    Shapiro, Charles
    Leone, Gustavo
    CANCER RESEARCH, 2009, 69
  • [46] Functional Reprogramming of the Tumor Stroma by IL-12 Engineered T Cells is Required for Anti-tumor Immunity
    Kerkar, Sid P.
    Reger, Robert
    Muranski, Pawel
    Yu, Zhiya
    Palmer, Douglas
    Chinnasamy, Dhanalakshmi
    Klebanoff, Christopher A.
    Ji, Yun
    Gattinoni, Luca
    Rosenberg, Steven A.
    Trinchieri, Giorgio
    Restifo, Nicholas P.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 861 - 861
  • [47] IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation
    Dowling, John P. P.
    Nikitin, Pavel A. A.
    Shen, Fang
    Shukla, Halley
    Finn, James P. P.
    Patel, Nirja
    Swider, Cezary
    Bingaman-Steele, Jamie L. L.
    Nicolescu, Chris
    Sikorski, Eden L.
    Greenawalt, Evan J. J.
    Morin, Michael J. J.
    Robinson, Matthew K. K.
    Lundgren, Karen
    Harman, Benjamin C. C.
    MABS, 2023, 15 (01)
  • [48] The role of B-1 cells in cancer progression and anti-tumor immunity
    Rodriguez-Zhurbenko, Nely
    Hernandez, Ana M.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [49] MALT1-induced Roquin cleavage in T cells and CAR T cells is critical for anti-tumor immunity
    Negraschusl, Arlinda
    Holtermann, Anne
    Edelmann, Stephanie
    Rupp, Luise
    Fuechsl, Franziska
    Krackhardt, Angela
    Schmitz, Marc
    Kobold, Sebastian
    Heissmeyer, Vigo
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 340 - 340
  • [50] Effective anti-tumor immunity induced by immunization with total tumor RNA
    Granstein, R. D.
    Stohl, L.
    Ding, W.
    Healey, D.
    Tcherepanova, I.
    Nicolette, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S159 - S159
12345